Quadmix (pge1 recalls
The FDA has published 2 recalls involving Quadmix (pge1 since 2023. The latest was reported on 18 Jan 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Jan 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why quadmix (pge1 is recalled
Companies
By year
All quadmix (pge1 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine recalled | Northern VA Compounders Pllc | Sterility | Nationwide |
| Drug | CLASS II | QuadMix Injectable (PGE1/Papaverine HCl/Phentolamine recalled | Northern VA Compounders Pllc | Sterility | Nationwide |
Should you stop taking Quadmix (pge1?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.